| Adverse events | Adverse event in two or more patients | Treatment-emergent events | Drug-related treatment-emergent events |
| Oedema peripheral | 8 (36.4) | 8 (36.4) | 6 (27.3) |
| Dyspnoea | 7 (31.8) | 7 (31.8) | 6 (27.3) |
| Dyspepsia | 5 (22.7) | 5 (22.7) | 3 (13.6) |
| Nasopharyngitis | 5 (22.7) | 5 (22.7) | 0 (0) |
| Headache | 4 (18.2) | 4 (18.2) | 3 (13.6) |
| Feeling hot | 3 (13.6) | 3 (13.6) | 3 (13.6) |
| Bronchitis | 3 (13.6) | 3 (13.6) | 0 (0) |
| Pancytopenia | 2 (9.1) | 2 (9.1) | 2 (9.1) |
| Gastroenteritis | 2 (9.1) | 2 (9.1) | 1 (4.5) |
| Hypoxaemia | 2 (9.1) | 2 (9.1) | 2 (9.1) |
| Hypotension | 2 (9.1) | 2 (9.1) | 1 (4.5) |
| Respiratory failure | 2 (9.1) | 2 (9.1) | 1 (4.5) |
| Right ventricular failure | 2 (9.1) | 2 (9.1) | 1 (4.5) |
| Respiratory tract infection | 2 (9.1) | 2 (9.1) | 0 (0) |
| Pulmonary fibrosis | 2 (9.1) | 1 (4.5) | 0 (0) |
| Diarrhoea | 2 (9.1) | 2 (9.1) | 0 (0) |
| Total number of patients reporting any event | 21 (95.5) | 20 (90.9) | 15 (68.2) |
Data are presented as n (%).